Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pdl Biopharma, Inc. (PDLI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pdl Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 882104.
Total stock buying since 2014: $32,222,958.
Total stock sales since 2014: $3,888,296.
Total stock option exercises since 2014: $270,128.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 187,061 | $383,475 | 0 | $0 | 0 | $0 |
| 2020 | 12,359,813 | $31,467,746 | 1,520,486 | $3,888,296 | 163,130 | $270,128 |
| 2017 | 25,000 | $49,400 | 0 | $0 | 0 | $0 |
| 2016 | 10,000 | $29,950 | 0 | $0 | 0 | $0 |
| 2015 | 55,590 | $243,907 | 0 | $0 | 0 | $0 |
| 2014 | 6,000 | $48,480 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-02 | 187,061 | $383,475 | 0 | $0 | 0 | $0 |
| 2020-12 | 12,359,813 | $31,467,746 | 1,197,934 | $3,112,573 | 66,050 | $108,322 |
| 2020-11 | 0 | $0 | 322,552 | $775,723 | 97,080 | $161,806 |
| 2017-03 | 25,000 | $49,400 | 0 | $0 | 0 | $0 |
| 2016-08 | 10,000 | $29,950 | 0 | $0 | 0 | $0 |
| 2015-12 | 35,590 | $127,377 | 0 | $0 | 0 | $0 |
| 2015-08 | 20,000 | $116,530 | 0 | $0 | 0 | $0 |
| 2014-11 | 6,000 | $48,480 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-01 | Mule Edward A | Buy | 187,061 | 2.05 | 383,475 |
| 2020-12-30 | Gryska David W | Sale | 20,000 | 2.74 | 54,800 |
| 2020-12-30 | Mule Edward A | Buy | 6,325,213 | 2.50 | 15,813,032 |
| 2020-12-29 | Mule Edward A | Buy | 268,600 | 2.69 | 722,534 |
| 2020-12-28 | Mule Edward A | Buy | 235,000 | 2.70 | 634,500 |
| 2020-12-24 | Mule Edward A | Buy | 128,000 | 2.65 | 339,200 |
| 2020-12-23 | Mule Edward A | Buy | 485,000 | 2.60 | 1,261,000 |
| 2020-12-22 | Mclaughlin John Peter | Sale | 277,934 | 2.61 | 724,573 |
| 2020-12-22 | Mule Edward A | Buy | 850,000 | 2.59 | 2,201,500 |
| 2020-12-21 | Mclaughlin John Peter | Sale | 50,000 | 2.62 | 131,200 |
| 2020-12-21 | Mule Edward A | Buy | 230,000 | 2.63 | 604,900 |
| 2020-12-17 | Mule Edward A | Buy | 398,000 | 2.61 | 1,038,780 |
| 2020-12-16 | Monnet Dominique (President and CEO) | Sale | 500,000 | 2.60 | 1,300,000 |
| 2020-12-16 | Stone Christopher Lewis (VP, Gen. Counsel & Secretary) | Sale | 200,000 | 2.56 | 512,000 |
| 2020-12-16 | Gryska David W | Sale | 75,000 | 2.68 | 201,000 |
| 2020-12-16 | Mule Edward A | Buy | 1,350,000 | 2.58 | 3,483,000 |
| 2020-12-15 | Mule Edward A | Buy | 1,000,000 | 2.59 | 2,590,000 |
| 2020-12-14 | Mule Edward A | Buy | 640,000 | 2.62 | 1,676,800 |
| 2020-12-11 | Mule Edward A | Buy | 450,000 | 2.45 | 1,102,500 |
| 2020-12-05 | Gryska David W | Option Ex | 66,050 | 1.64 | 108,322 |
| 2020-12-03 | Gryska David W | Sale | 75,000 | 2.52 | 189,000 |
| 2020-11-23 | O'farrell Elizabeth G. | Sale | 25,826 | 2.44 | 63,015 |
| 2020-11-23 | Gryska David W | Sale | 50,000 | 2.43 | 121,500 |
| 2020-11-20 | Bazaar Alan Lee | Sale | 33,435 | 2.42 | 81,013 |
| 2020-11-18 | O'farrell Elizabeth G. | Sale | 63,291 | 2.38 | 150,695 |
| 2020-11-18 | Bazaar Alan Lee | Option Ex | 37,080 | 1.71 | 63,406 |
| 2020-11-18 | Gryska David W | Sale | 50,000 | 2.39 | 119,500 |
| 2020-11-18 | Gryska David W | Option Ex | 60,000 | 1.64 | 98,400 |
| 2020-11-17 | Gryska David W | Sale | 100,000 | 2.40 | 240,000 |
| 2017-03-24 | Garcia Peter S (Vice President, CFO) | Buy | 25,000 | 1.98 | 49,400 |
| 2016-08-09 | Garcia Peter S (Vice President, CFO) | Buy | 10,000 | 3.00 | 29,950 |
| 2015-12-15 | Garcia Peter S (Vice President, CFO) | Buy | 5,000 | 3.64 | 18,200 |
| 2015-12-14 | Garcia Peter S (Vice President, CFO) | Buy | 10,000 | 3.42 | 34,250 |
| 2015-12-07 | Pietzke Steffen (Controller and CAO) | Buy | 20,590 | 3.64 | 74,927 |
| 2015-08-14 | Garcia Peter S (Vice President, CFO) | Buy | 10,000 | 5.79 | 57,930 |
| 2015-08-13 | Garcia Peter S (Vice President, CFO) | Buy | 10,000 | 5.86 | 58,600 |
| 2014-11-26 | Selick Harold E | Buy | 6,000 | 8.08 | 48,480 |
Insider trading activities including stock purchases, stock sales, and option exercises of PDLI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pdl Biopharma, Inc. (symbol PDLI, CIK number 882104) see the Securities and Exchange Commission (SEC) website.